
### [MONDO:0002691](http://purl.obolibrary.org/obo/MONDO_0002691)
**Label:** liver cancer

**Subclasses:** [MONDO:0016216](http://purl.obolibrary.org/obo/MONDO_0016216) (adult hepatocellular carcinoma), [MONDO:0018666](http://purl.obolibrary.org/obo/MONDO_0018666) (hepatoblastoma), [MONDO:0007256](http://purl.obolibrary.org/obo/MONDO_0007256) (hepatocellular carcinoma), [MONDO:0015072](http://purl.obolibrary.org/obo/MONDO_0015072) (primary hepatic neuroendocrine carcinoma), [MONDO:0018055](http://purl.obolibrary.org/obo/MONDO_0018055) (pediatric hepatocellular carcinoma), [MONDO:0015073](http://purl.obolibrary.org/obo/MONDO_0015073) (gallbladder neuroendocrine tumor), [MONDO:0014281](http://purl.obolibrary.org/obo/MONDO_0014281) (cholangiocarcinoma, susceptibility to), [MONDO:0019087](http://purl.obolibrary.org/obo/MONDO_0019087) (cholangiocarcinoma), 

**Corr. equiv. classes:** [Orphanet:88673](http://www.orpha.net/ORDO/Orphanet_88673), [Orphanet:100085](http://www.orpha.net/ORDO/Orphanet_100085), [Orphanet:100086](http://www.orpha.net/ORDO/Orphanet_100086), [Orphanet:70567](http://www.orpha.net/ORDO/Orphanet_70567), [Orphanet:33402](http://www.orpha.net/ORDO/Orphanet_33402), [Orphanet:449](http://www.orpha.net/ORDO/Orphanet_449), [OMIM:114550](http://purl.obolibrary.org/obo/OMIM_114550), [OMIM:615619](http://purl.obolibrary.org/obo/OMIM_615619), [Orphanet:210159](http://www.orpha.net/ORDO/Orphanet_210159), 

**Class expressions from DL-Learner:**

- [HP:0002012](http://purl.obolibrary.org/obo/HP_0002012) (Abnormality of the abdominal organs) 31.15%
- [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 29.89%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 28.92%
- Thing 28.91%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 28.91%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 25.45%
- [HP:0011024](http://purl.obolibrary.org/obo/HP_0011024) (Abnormality of the gastrointestinal tract) 25.01%
- [HP:0007378](http://purl.obolibrary.org/obo/HP_0007378) (Neoplasm of the gastrointestinal tract) 23.74%
- [HP:0002027](http://purl.obolibrary.org/obo/HP_0002027) (Abdominal pain) 22.60%
- [HP:0012378](http://purl.obolibrary.org/obo/HP_0012378) (Fatigue) 22.48%
- [HP:0012531](http://purl.obolibrary.org/obo/HP_0012531) (Pain) 20.27%
- [HP:0025142](http://purl.obolibrary.org/obo/HP_0025142) (Constitutional symptom) 19.86%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 19.60%
- [HP:0025032](http://purl.obolibrary.org/obo/HP_0025032) (Abnormality of digestive system physiology) 18.86%
- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) 18.33%


